AAAAAA

   
Results: 1-9 |
Results: 9
Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients
Authors: Chalasani, N Gorski, JC Horlander, JC Craven, R Hoen, H Maya, J Brater, DC
Citation: N. Chalasani et al., Effects of albumin/furosemide mixtures on responses to furosemide in hypoalbuminemic patients, J AM S NEPH, 12(5), 2001, pp. 1010-1016
Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts
Authors: Chalasani, N Gorski, JC Patel, NH Hall, SD Galinsky, RE
Citation: N. Chalasani et al., Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: Effects of transjugular intrahepatic portosystemic shunts, HEPATOLOGY, 34(6), 2001, pp. 1103-1108
In vivo effect of clarithromycin on multiple cytochrome P450S
Authors: Bruce, MA Hall, SD Haehner-Daniels, BD Gorski, JC
Citation: Ma. Bruce et al., In vivo effect of clarithromycin on multiple cytochrome P450S, DRUG META D, 29(7), 2001, pp. 1023-1028
Urinary protein binding does not affect response to furosemide in patientswith nephrotic syndrome
Authors: Agarwal, R Gorski, JC Sundblad, K Brater, DC
Citation: R. Agarwal et al., Urinary protein binding does not affect response to furosemide in patientswith nephrotic syndrome, J AM S NEPH, 11(6), 2000, pp. 1100-1105
The effect of hormone replacement therapy on CYP3A activity
Authors: Gorski, JC Wang, ZQ Heahner-Daniels, BD Wrighton, SA Hall, SD
Citation: Jc. Gorski et al., The effect of hormone replacement therapy on CYP3A activity, CLIN PHARM, 68(4), 2000, pp. 412-417
In vivo effects of interleukin-10 on human cytochrome P450 activity
Authors: Gorski, JC Hall, SD Becker, P Affrime, MB Cutler, DL Haehner-Daniels, B
Citation: Jc. Gorski et al., In vivo effects of interleukin-10 on human cytochrome P450 activity, CLIN PHARM, 67(1), 2000, pp. 32-43
Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily
Authors: Gorski, JC Jones, DR Hamman, MA Wrighton, SA Hall, SD
Citation: Jc. Gorski et al., Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily, XENOBIOTICA, 29(9), 1999, pp. 931-944
Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation
Authors: Jones, DR Gorski, JC Hamman, MA Mayhew, BS Rider, S Hall, SD
Citation: Dr. Jones et al., Diltiazem inhibition of cytochrome P-450 3A activity is due to metabolite intermediate complex formation, J PHARM EXP, 290(3), 1999, pp. 1116-1125
In vivo comparison of putative probes of CYP3A4/5 activity: Erythromycin, dextromethorphan, and verapamil
Authors: Krecic-Shepard, IE Barnas, CR Slimko, J Gorski, JC Wainer, IW Schwartz, JB
Citation: Ie. Krecic-shepard et al., In vivo comparison of putative probes of CYP3A4/5 activity: Erythromycin, dextromethorphan, and verapamil, CLIN PHARM, 66(1), 1999, pp. 40-50
Risultati: 1-9 |